HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 44.69
+1.01 (2.31%)
At close: Sep 30, 2026
HitGen Market Cap
HitGen has a market cap or net worth of 17.91 billion as of October 2, 2026. Its market cap has increased by 87.80% in one year.
Market Cap
17.91B
Enterprise Value
17.26B
Revenue
644.54M
Ranking
n/a
PE Ratio
127.16
Stock Price
44.69
ChartMarket Cap Chart
Since April 16, 2020, HitGen's market cap has decreased from 18.86B to 17.91B, a decrease of -5.08%. That is a compound annual growth rate of -0.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 17.91B | 91.17% |
| Dec 31, 2025 | 9.37B | 90.34% |
| Dec 31, 2024 | 4.92B | -17.81% |
| Dec 29, 2023 | 5.99B | 10.86% |
| Dec 30, 2022 | 5.40B | -42.61% |
| Dec 31, 2021 | 9.41B | -22.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evopoint Biosciences | 21.51B |
| Hebei Changshan Biochemical Pharmaceutical | 21.08B |
| Xiamen Amoytop Biotech | 21.02B |
| Sino Biological,Inc. | 19.34B |
| Yili Chuanning Biotechnology | 18.28B |
| Sinocelltech Group | 17.43B |
| BrightGene Bio-Medical Technology | 15.59B |
| GemPharmatech | 15.52B |